HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $453,472 | +7.8% | 11,871 | +1.8% | 0.04% | -7.9% |
| Q2 2023 | $420,468 | +4.9% | 11,657 | +11.1% | 0.04% | +52.0% |
| Q1 2023 | $400,728 | -36.2% | 10,493 | -4.9% | 0.02% | -60.3% |
| Q4 2022 | $627,778 | +39.8% | 11,033 | -2.9% | 0.06% | +270.6% |
| Q3 2022 | $449,000 | +31.7% | 11,367 | +46.8% | 0.02% | -63.8% |
| Q2 2022 | $341,000 | +11266.7% | 7,741 | +2877.3% | 0.05% | +4600.0% |
| Q4 2018 | $3,000 | -40.0% | 260 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $5,000 | 0.0% | 260 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,000 | – | 260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |